- Home
- LCFY vs SILO Comparison
LCFY vs SILO Comparison
Compare LCFY & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- SILO
- Stock Information
- Founded
- LCFY 2009
- SILO 2010
- Country
- LCFY Australia
- SILO United States
- Employees
- LCFY N/A
- SILO N/A
- Industry
- LCFY
- SILO Apparel
- Sector
- LCFY
- SILO Consumer Discretionary
- Exchange
- LCFY Nasdaq
- SILO Nasdaq
- Market Cap
- LCFY 5.9M
- SILO 5.9M
- IPO Year
- LCFY 2022
- SILO N/A
- Fundamental
- Price
- LCFY $6.02
- SILO $0.59
- Analyst Decision
- LCFY
- SILO
- Analyst Count
- LCFY 0
- SILO 0
- Target Price
- LCFY N/A
- SILO N/A
- AVG Volume (30 Days)
- LCFY 1.5M
- SILO 295.0K
- Earning Date
- LCFY 10-10-2025
- SILO 08-13-2025
- Dividend Yield
- LCFY N/A
- SILO N/A
- EPS Growth
- LCFY N/A
- SILO N/A
- EPS
- LCFY N/A
- SILO N/A
- Revenue
- LCFY $2,231,313.00
- SILO $72,102.00
- Revenue This Year
- LCFY N/A
- SILO $1.86
- Revenue Next Year
- LCFY N/A
- SILO N/A
- P/E Ratio
- LCFY N/A
- SILO N/A
- Revenue Growth
- LCFY N/A
- SILO N/A
- 52 Week Low
- LCFY $2.51
- SILO $0.41
- 52 Week High
- LCFY $13.98
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- LCFY 65.55
- SILO 42.06
- Support Level
- LCFY $3.67
- SILO $0.59
- Resistance Level
- LCFY $6.94
- SILO $0.65
- Average True Range (ATR)
- LCFY 0.64
- SILO 0.04
- MACD
- LCFY 0.20
- SILO -0.01
- Stochastic Oscillator
- LCFY 71.87
- SILO 12.63
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.